<?xml version="1.0" encoding="windows-1251"?>
<rss version="0.92">
<channel>
<title>Ruslan Bondar Site - viagra/history</title>
<link>http://rus.leaping.net/viagra/history</link>
<description>History/revisions of Ruslan Bondar Site/viagra/history</description>
<language>en-us</language>
<item>
<title>2005-09-17 17:17:22</title>
<link>http://rus.leaping.net/viagra/history/show?time=2005-09-17+17%3A17%3A22</link>
<description>&lt;a name="h310-1">&lt;/a>&lt;h1> History of&amp;nbsp;Viagra &lt;/h1>
&lt;br />&lt;a name="p310-1">&lt;/a>&lt;p class="auto" id="p310-1">
Sildenafil (compound &lt;span class="nobr">UK-92&lt;/span>,480) was&amp;nbsp;synthesized by&amp;nbsp;a group of&amp;nbsp;pharmaceutical chemists working at&amp;nbsp;Pfizer's Sandwich, Kent research facility. It&amp;nbsp;was initially studied for&amp;nbsp;use in&amp;nbsp;hypertension (high blood pressure) and&amp;nbsp;angina pectoris (a form of&amp;nbsp;ischaemic cardiovascular disease). Phase I&amp;nbsp;clinical trial`s under the&amp;nbsp;direction of&amp;nbsp;Ian Osterloh suggested that the&amp;nbsp;drug had&amp;nbsp;little effect on&amp;nbsp;angina, but&amp;nbsp;that it&amp;nbsp;could induce marked penile erection`s. Pfizer therefore decided to&amp;nbsp;market it&amp;nbsp;for erectile dysfunction, rather than for&amp;nbsp;angina. The&amp;nbsp;drug was&amp;nbsp;patented in&amp;nbsp;1996, approved for&amp;nbsp;use in&amp;nbsp;erectile dysfunction by&amp;nbsp;the Food and&amp;nbsp;Drug Administration on&amp;nbsp;March 27, 1998, becoming the&amp;nbsp;first pill approved to&amp;nbsp;treat erectile dysfunction in&amp;nbsp;the United States, and&amp;nbsp;offered for&amp;nbsp;sale in&amp;nbsp;the United States later that year.  It&amp;nbsp;soon became a&amp;nbsp;great success: annual sales of&amp;nbsp;Viagra in&amp;nbsp;the period 1999&amp;ndash;2001 exceeded billion. &lt;/p>&lt;br />&lt;a name="p310-2">&lt;/a>&lt;p class="auto" id="p310-2">
 The&amp;nbsp;British press portrayed Peter Dunn and&amp;nbsp;Albert Wood as&amp;nbsp;the inventors of&amp;nbsp;the drug, a&amp;nbsp;claim which Pfizer disputes.Bellis, Mary. the patenting of&amp;nbsp;an aphrodisiac." &lt;span class="missingpage">About.com&lt;/span>&lt;a href="http://rus.leaping.net/About/com/edit?add=1" title="Ñîçäàòü ýòó ñòðàíèöó">?&lt;/a>. Their names are&amp;nbsp;on&amp;nbsp;the manufacturing patent application drug, but&amp;nbsp;Pfizer claims this is&amp;nbsp;only for&amp;nbsp;convenience.&lt;/p>&lt;br />&lt;a name="p310-3">&lt;/a>&lt;p class="auto" id="p310-3">
 Even though sildenafil is&amp;nbsp;only available by&amp;nbsp;prescription from a&amp;nbsp;doctor, it&amp;nbsp;was advertised directly to&amp;nbsp;consumers on&amp;nbsp;US TV&amp;nbsp;(famously being endorsed by&amp;nbsp;Bob Dole). Numerous sites on&amp;nbsp;the Internet offer Viagra for&amp;nbsp;sale after an&amp;nbsp;&amp;#147;online consultation&amp;#148;, a&amp;nbsp;mere web&amp;nbsp;questionnaire. The&amp;nbsp;&amp;#147;Viagra&amp;#148; name has&amp;nbsp;become so&amp;nbsp;well known that many fake aphrodisiac`s now&amp;nbsp;call themselves &amp;#147;herbal Viagra&amp;#148; or&amp;nbsp;are presented as&amp;nbsp;blue tablets imitating the&amp;nbsp;shape and&amp;nbsp;colour of&amp;nbsp;Pfizer's product. Viagra is&amp;nbsp;also informally known as&amp;nbsp;&amp;#147;Vitamin V&amp;#148;, &amp;#147;the Blue Pill&amp;#148;, as&amp;nbsp;well as&amp;nbsp;various other nicknames.&lt;/p>&lt;br />&lt;a name="p310-4">&lt;/a>&lt;p class="auto" id="p310-4">
 Pfizer's worldwide patents on&amp;nbsp;sildenafil citrate will expire in&amp;nbsp;2011–2013. The&amp;nbsp;United Kingdom patent held by&amp;nbsp;Pfizer on&amp;nbsp;the use&amp;nbsp;of&amp;nbsp;inhibitors (see below) as&amp;nbsp;treatment of&amp;nbsp;impotence was&amp;nbsp;invalidated in&amp;nbsp;2000 because of&amp;nbsp;obviousness; this decision was&amp;nbsp;upheld on&amp;nbsp;appeal in&amp;nbsp;2002.&lt;/p></description>
</item>
<item>
<title>2005-09-17 17:17:05</title>
<link>http://rus.leaping.net/viagra/history/show?time=2005-09-17+17%3A17%3A05</link>
<description>edited by 193.238.212.171</description>
</item>
</channel>
</rss>

